老年肿瘤患者COVID-19重症结局的老年医学风险因素:CCC19队列研究
本研究基于CCC19多中心注册队列,纳入5671例60岁及以上肿瘤合并COVID-19患者,评估由年龄、改良Charlson共病指数和ECOG体能状态构成的CCC19老年风险指数与COVID-19严重程度及30天死亡率的关系。该指数或可为临床提供简便的风险分层工具。
要点
- CCC19老年风险指数由年龄、改良Charlson共病指数和ECOG体能状态构成。
核心结论
- CCC19老年风险指数与肿瘤合并COVID-19老年患者的COVID-19严重程度和30天死亡率强烈相关。
- 该指数基于易获取的临床因素,或可帮助临床医生识别COVID-19重症和死亡风险较高的老年人。
研究设计与样本
- 研究为队列研究,纳入2020年3月17日至2021年6月6日期间报告至CCC19跨国多中心注册库的患者。
- 纳入标准为年龄60岁及以上、当前或既往肿瘤诊断(排除非浸润性肿瘤及癌前或非恶性情况)、当前或既往实验室确诊COVID-19。
- 排除标准包括年龄未知、数据缺失导致老年风险指标无法计算、数据质量不足或随访不完整导致COVID-19严重程度未知。
- 暴露为CCC19老年风险指数,主要结局为COVID-19严重程度,次要结局为30天全因死亡率,均在完整数据集中评估。
- 采用序数和二元logistic回归模型估计调整OR及95%CI。
主要发现
- 共纳入5671例肿瘤合并COVID-19患者,中位随访56天(IQR 22-120),中位年龄72岁(IQR 66-79)。
关键数值与推荐
- CCC19老年风险指数由年龄、改良Charlson共病指数和ECOG体能状态构成。
临床怎么用
- 临床可基于年龄、改良Charlson共病指数和ECOG体能状态计算CCC19老年风险指数,对60岁及以上肿瘤合并COVID-19患者进行风险分层。
- 对指数评估为高风险的患者,应加强COVID-19重症和死亡风险的监测与临床关注。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Older age is associated with poorer outcomes of SARS-CoV-2 infection, although the heterogeneity of ageing results in some older adults being at greater risk than others. The objective of this study was to quantify the association of a novel geriatric risk index, comprising age, modified Charlson comorbidity index, and Eastern Cooperative Oncology Group performance status, with COVID-19 severity and 30-day mortality among older adults with cancer. METHODS: In this cohort study, we enrolled patients aged 60 years and older with a current or previous cancer diagnosis (excluding those with non-invasive cancers and premalignant or non-malignant conditions) and a current or previous laboratory-confirmed COVID-19 diagnosis who reported to the COVID-19 and Cancer Consortium (CCC19) multinational, multicentre, registry between March 17, 2020, and June 6, 2021. Patients were also excluded for unknown age, missing data resulting in unknown geriatric risk measure, inadequate data quality, or incomplete follow-up resulting in unknown COVID-19 severity. The exposure of interest was the CCC19 geriatric risk index. The primary outcome was COVID-19 severity and the secondary outcome was 30-day all-cause mortality; both were assessed in the full dataset. Adjusted odds ratios (ORs) and 95% CIs were estimated from ordinal and binary logistic regression models. FINDINGS: 5671 patients with cancer and COVID-19 were included in the analysis. Median follow-up time was 56 days (IQR 22-120), and median age was 72 years (IQR 66-79). The CCC19 geriatric risk index identified 2365 (41·7%) patients as standard risk, 2217 (39·1%) patients as intermediate risk, and 1089 (19·2%) as high risk. 36 (0·6%) patients were excluded due to non-calculable geriatric risk index. Compared with standard-risk patients, high-risk patients had significantly higher COVID-19 severity (adjusted OR 7·24; 95% CI 6·20-8·45). 920 (16·2%) of 5671 patients died within 30 days of a COVID-19 diagnosis, including 161 (6·8%) of 2365 standard-risk patients, 409 (18·5%) of 2217 intermediate-risk patients, and 350 (32·1%) of 1089 high-risk patients. High-risk patients had higher adjusted odds of 30-day mortality (adjusted OR 10·7; 95% CI 8·54-13·5) than standard-risk patients. INTERPRETATION: The CCC19 geriatric risk index was strongly associated with COVID-19 severity and 30-day mortality. Our CCC19 geriatric risk index, based on readily available clinical factors, might provide clinicians with an easy-to-use risk stratification method to identify older adults most at risk for severe COVID-19 as well as mortality. FUNDING: US National Institutes of Health National Cancer Institute Cancer Center.
引用
- Elkrief A, Hennessy C, Kuderer NM, et al. Geriatric risk factors for serious COVID-19 outcomes among older adults with cancer: a cohort study from the COVID-19 and Cancer Consortium. Lancet Healthy Longev. 2022. PMID: 35187516. doi:10.1016/S2666-7568(22)00009-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。